{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:10:54Z","timestamp":1771510254322,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft","award":["SFB841"],"award-info":[{"award-number":["SFB841"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB841"],"award-info":[{"award-number":["SFB841"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO306"],"award-info":[{"award-number":["KFO306"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO306"],"award-info":[{"award-number":["KFO306"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00330-018-5614-9","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T13:45:06Z","timestamp":1531748706000},"page":"818-828","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-2082","authenticated-orcid":false,"given":"S.","family":"Keller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sedlacik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Buchert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Avanesov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zenouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kooijman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fiehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"5614_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2559.2011.03853.x","volume":"60","author":"B Portmann","year":"2012","unstructured":"Portmann B, Zen Y (2012) Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation. Histopathology 60:236\u2013248","journal-title":"Histopathology"},{"key":"5614_CR2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.15403\/jgld.2014.1121.254.vac","volume":"25","author":"JD Kovac","year":"2016","unstructured":"Kovac JD, Weber MA (2016) Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: an Update on MR Imaging Findings with Recent Developments. J Gastrointestin Liver Dis 25:517\u2013524","journal-title":"J Gastrointestin Liver Dis"},{"key":"5614_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.20506","volume":"41","author":"M Ziol","year":"2005","unstructured":"Ziol M, Handra-Luca A, Kettaneh A et al (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48\u201354","journal-title":"Hepatology"},{"key":"5614_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L Castera","year":"2005","unstructured":"Castera L, Vergniol J, Foucher J et al (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128:343\u2013350","journal-title":"Gastroenterology"},{"key":"5614_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/gut.2005.069153","volume":"55","author":"J Foucher","year":"2006","unstructured":"Foucher J, Chanteloup E, Vergniol J et al (2006) Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55:403\u2013408","journal-title":"Gut"},{"key":"5614_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289\u2013293","journal-title":"Hepatology"},{"key":"5614_CR7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","volume":"146","author":"C Corpechot","year":"2014","unstructured":"Corpechot C, Gaouar F, El Naggar A et al (2014) Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology 146:970\u2013979 quiz e915-976","journal-title":"Gastroenterology"},{"key":"5614_CR8","doi-asserted-by":"publisher","first-page":"e0164224","DOI":"10.1371\/journal.pone.0164224","volume":"11","author":"H Ehlken","year":"2016","unstructured":"Ehlken H, Wroblewski R, Corpechot C et al (2016) Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis. PLoS One 11:e0164224","journal-title":"PLoS One"},{"key":"5614_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2214\/AJR.07.2086","volume":"189","author":"B Taouli","year":"2007","unstructured":"Taouli B, Tolia AJ, Losada M et al (2007) Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 189:799\u2013806","journal-title":"AJR Am J Roentgenol"},{"key":"5614_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/jmri.21227","volume":"28","author":"B Taouli","year":"2008","unstructured":"Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V (2008) Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 28:89\u201395","journal-title":"J Magn Reson Imaging"},{"key":"5614_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/hep.21747","volume":"46","author":"M Lewin","year":"2007","unstructured":"Lewin M, Poujol-Robert A, Boelle PY et al (2007) Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658\u2013665","journal-title":"Hepatology"},{"key":"5614_CR12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1148\/rg.296095512","volume":"29","author":"SC Faria","year":"2009","unstructured":"Faria SC, Ganesan K, Mwangi I et al (2009) MR imaging of liver fibrosis: current state of the art. Radiographics 29:1615\u20131635","journal-title":"Radiographics"},{"key":"5614_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jmri.25132","volume":"44","author":"Z Li","year":"2016","unstructured":"Li Z, Sun J, Chen L et al (2016) Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 44:98\u2013104","journal-title":"J Magn Reson Imaging"},{"key":"5614_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jmri.22081","volume":"31","author":"J Patel","year":"2010","unstructured":"Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B (2010) Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 31:589\u2013600","journal-title":"J Magn Reson Imaging"},{"key":"5614_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/liv.13058","volume":"36","author":"HA Dyvorne","year":"2016","unstructured":"Dyvorne HA, Jajamovich GH, Bane O et al (2016) Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection. Liver Int 36:659\u2013666","journal-title":"Liver Int"},{"key":"5614_CR16","doi-asserted-by":"publisher","first-page":"20120653","DOI":"10.1259\/bjr.20120653","volume":"86","author":"H Nilsson","year":"2013","unstructured":"Nilsson H, Blomqvist L, Douglas L et al (2013) Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis. Br J Radiol 86:20120653","journal-title":"Br J Radiol"},{"key":"5614_CR17","doi-asserted-by":"publisher","unstructured":"Juluru K, Talal AH, Yantiss RK et al (2016) Diagnostic accuracy of intracellular uptake rates calculated using dynamic Gd-EOB-DTPA-enhanced MRI for hepatic fibrosis stage. J Magn Reson Imaging. https:\/\/doi.org\/10.1002\/jmri.25431","DOI":"10.1002\/jmri.25431"},{"key":"5614_CR18","doi-asserted-by":"publisher","first-page":"e0129621","DOI":"10.1371\/journal.pone.0129621","volume":"10","author":"W Zhang","year":"2015","unstructured":"Zhang W, Kong X, Wang ZJ, Luo S, Huang W, Zhang LJ (2015) Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats. PLoS One 10:e0129621","journal-title":"PLoS One"},{"key":"5614_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1148\/radiol.12110337","volume":"263","author":"S Sourbron","year":"2012","unstructured":"Sourbron S, Sommer WH, Reiser MF, Zech CJ (2012) Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. Radiology 263:874\u2013883","journal-title":"Radiology"},{"key":"5614_CR20","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"L Sandrin","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM et al (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29:1705\u20131713","journal-title":"Ultrasound Med Biol"},{"key":"5614_CR21","volume-title":"Foundations of clinical research: application to practice","author":"L Portney","year":"1999","unstructured":"Portney L, Watkins M (1999) Foundations of clinical research: application to practice. Prentice Hall, Upper Saddle River"},{"key":"5614_CR22","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/jmri.25431","volume":"45","author":"K Juluru","year":"2017","unstructured":"Juluru K, Talal AH, Yantiss RK et al (2017) Diagnostic accuracy of intracellular uptake rates calculated using dynamic Gd-EOB-DTPA-enhanced MRI for hepatic fibrosis stage. J Magn Reson Imaging 45:1177\u20131185","journal-title":"J Magn Reson Imaging"},{"key":"5614_CR23","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/mrm.26520","volume":"78","author":"J Ning","year":"2017","unstructured":"Ning J, Yang Z, Xie S, Sun Y, Yuan C, Chen H (2017) Hepatic function imaging using dynamic Gd-EOB-DTPA enhanced MRI and pharmacokinetic modeling. Magn Reson Med 78:1488\u20131495","journal-title":"Magn Reson Med"},{"key":"5614_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s003300050125","volume":"7","author":"M Bollow","year":"1997","unstructured":"Bollow M, Taupitz M, Hamm B, Staks T, Wolf KJ, Weinmann HJ (1997) Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation. Eur Radiol 7:126\u2013132","journal-title":"Eur Radiol"},{"key":"5614_CR25","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00330-008-0929-6","volume":"18","author":"FT Tschirch","year":"2008","unstructured":"Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D (2008) Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 18:1577\u20131586","journal-title":"Eur Radiol"},{"key":"5614_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/01.rli.0000184756.66360.d3","volume":"40","author":"M Rohrer","year":"2005","unstructured":"Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40:715\u2013724","journal-title":"Invest Radiol"},{"key":"5614_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.5009\/gnl16079","volume":"11","author":"TP Hennedige","year":"2017","unstructured":"Hennedige TP, Wang G, Leung FP et al (2017) Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B. Gut Liver 11:401\u2013408","journal-title":"Gut Liver"},{"key":"5614_CR28","doi-asserted-by":"publisher","unstructured":"Feier D, Balassy C, Bastati N, Fragner R, Wrba F, Ba-Ssalamah A (2015) The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis-a multiparametric approach. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-015-3830-0","DOI":"10.1007\/s00330-015-3830-0"},{"key":"5614_CR29","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/j.ejrad.2011.10.024","volume":"81","author":"JD Kovac","year":"2012","unstructured":"Kovac JD, Dakovic M, Stanisavljevic D et al (2012) Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases. Eur J Radiol 81:2500\u20132506","journal-title":"Eur J Radiol"},{"key":"5614_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/hep.25610","volume":"56","author":"QB Wang","year":"2012","unstructured":"Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology 56:239\u2013247","journal-title":"Hepatology"},{"key":"5614_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2214\/AJR.10.4580","volume":"196","author":"Y Wang","year":"2011","unstructured":"Wang Y, Ganger DR, Levitsky J et al (2011) Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 196:553\u2013561","journal-title":"AJR Am J Roentgenol"},{"key":"5614_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1148\/radiol.09090021","volume":"254","author":"B Taouli","year":"2010","unstructured":"Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254:47\u201366","journal-title":"Radiology"},{"key":"5614_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1148\/radiol.2493080080","volume":"249","author":"A Luciani","year":"2008","unstructured":"Luciani A, Vignaud A, Cavet M et al (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study. Radiology 249:891\u2013899","journal-title":"Radiology"},{"key":"5614_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/apt.13004","volume":"41","author":"KD Williamson","year":"2015","unstructured":"Williamson KD, Chapman RW (2015) Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC. Aliment Pharmacol Ther 41:149\u2013151","journal-title":"Aliment Pharmacol Ther"},{"key":"5614_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jhep.2012.10.013","volume":"58","author":"S Mamari Al","year":"2013","unstructured":"Al Mamari S, Djordjevic J, Halliday JS, Chapman RW (2013) Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol 58:329\u2013334","journal-title":"J Hepatol"},{"key":"5614_CR36","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.28256","volume":"63","author":"CY Ponsioen","year":"2016","unstructured":"Ponsioen CY, Chapman RW, Chazouilleres O et al (2016) Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process. Hepatology 63:1357\u20131367","journal-title":"Hepatology"},{"key":"5614_CR37","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1136\/gutjnl-2016-311452","volume":"65","author":"H Ehlken","year":"2016","unstructured":"Ehlken H, Wroblewski R, Corpechot C et al (2016) Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis. Gut 65:1230\u20131232","journal-title":"Gut"},{"key":"5614_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"European Association for the Study of the L","year":"2009","unstructured":"European Association for the Study of the L (2009) EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 51:237\u2013267","journal-title":"J Hepatol"},{"key":"5614_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.gastro.2008.03.076","volume":"135","author":"L Huwart","year":"2008","unstructured":"Huwart L, Sempoux C, Vicaut E et al (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135:32\u201340","journal-title":"Gastroenterology"},{"key":"5614_CR40","doi-asserted-by":"publisher","first-page":"e113846","DOI":"10.1371\/journal.pone.0113846","volume":"9","author":"PX Lu","year":"2014","unstructured":"Lu PX, Huang H, Yuan J et al (2014) Decreases in molecular diffusion, perfusion fraction and perfusion-related diffusion in fibrotic livers: a prospective clinical intravoxel incoherent motion MR imaging study. PLoS One 9:e113846","journal-title":"PLoS One"},{"key":"5614_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/RCT.0b013e3182a589be","volume":"38","author":"JH Yoon","year":"2014","unstructured":"Yoon JH, Lee JM, Baek JH et al (2014) Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr 38:110\u2013116","journal-title":"J Comput Assist Tomogr"},{"key":"5614_CR42","doi-asserted-by":"publisher","first-page":"e85658","DOI":"10.1371\/journal.pone.0085658","volume":"8","author":"M Haimerl","year":"2013","unstructured":"Haimerl M, Verloh N, Zeman F et al (2013) Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS One 8:e85658","journal-title":"PLoS One"},{"key":"5614_CR43","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s00330-012-2378-5","volume":"22","author":"T Heye","year":"2012","unstructured":"Heye T, Yang SR, Bock M et al (2012) MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol 22:1224\u20131232","journal-title":"Eur Radiol"},{"key":"5614_CR44","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.ejrad.2015.05.019","volume":"84","author":"C Cassinotto","year":"2015","unstructured":"Cassinotto C, Feldis M, Vergniol J et al (2015) MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity. Eur J Radiol 84:1459\u20131465","journal-title":"Eur J Radiol"},{"key":"5614_CR45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/jmri.25030","volume":"43","author":"Z Li","year":"2016","unstructured":"Li Z, Sun J, Hu X et al (2016) Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T. J Magn Reson Imaging 43:698\u2013703","journal-title":"J Magn Reson Imaging"},{"key":"5614_CR46","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s00330-015-3913-y","volume":"26","author":"H Hinrichs","year":"2016","unstructured":"Hinrichs H, Hinrichs JB, Gutberlet M et al (2016) Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC). Eur Radiol 26:1116\u20131124","journal-title":"Eur Radiol"},{"key":"5614_CR47","doi-asserted-by":"publisher","first-page":"e0193929","DOI":"10.1371\/journal.pone.0193929","volume":"13","author":"S Keller","year":"2018","unstructured":"Keller S, Aigner A, Zenouzi R et al (2018) Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis. PLoS One 13:e0193929","journal-title":"PLoS One"},{"key":"5614_CR48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/jmri.23668","volume":"36","author":"DR Martin","year":"2012","unstructured":"Martin DR, Lauenstein T, Kalb B et al (2012) Liver MRI and histological correlates in chronic liver disease on multiphase gadolinium-enhanced 3D gradient echo imaging. J Magn Reson Imaging 36:422\u2013429","journal-title":"J Magn Reson Imaging"},{"key":"5614_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.hepres.2004.03.007","volume":"29","author":"H Saito","year":"2004","unstructured":"Saito H, Tada S, Nakamoto N et al (2004) Efficacy of non-invasive elastometry on staging of hepatic fibrosis. Hepatol Res 29:97\u2013103","journal-title":"Hepatol Res"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-018-5614-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5614-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5614-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T01:15:47Z","timestamp":1604625347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-018-5614-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["5614"],"URL":"https:\/\/doi.org\/10.1007\/s00330-018-5614-9","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"9 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is J. Yamamura.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: Philips Healthcare (H. Kooijman).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise (R. Buchert).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 prospective\u2022 experimental study\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}